Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute systemic inflammation impairs endothelium-dependent dilatation in humans.
Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, MacAllister RJ, Vallance P. Hingorani AD, et al. Among authors: palacios m. Circulation. 2000 Aug 29;102(9):994-9. doi: 10.1161/01.cir.102.9.994. Circulation. 2000. PMID: 10961963 Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Current status of pediatric auditory brainstem implantation in inner ear malformations; consensus statement of the Third International Pediatric ABI Meeting.
Sennaroglu L, Lenarz T, Roland JT, Lee DJ, Colletti L, Behr R, Jiang D, Saeed SR, Casselman J, Manrique M, Diamante V, Freeman SRM, Lloyd SKW, Zarowski A, Offeciers E, Kameswaran M, de la Torre Diamante DA, Bilginer B, Thomas N, Bento R, Sennaroglu G, Yucel E, Bajin MD, Cole C, Martinez A, Loggins J, Eisenberg LS, Wilkinson EP, Bakey CA, Carter CL, Herrmann BS, Waltzman S, Shapiro W, Svirsky M, Pallares N, Diamante G, Heller F, Palacios M, Diamante LL, Chang W, Tong M, Wu H, Batuk MO, Yarali M, Cinar BC, Ozkan HB, Aslan F, Hallin K, Rask-Andersen H, Huarte A, Prieto-Matos C, Topsakal V, Hofkens-Van den Brandt A, Van Rompaey V, Boudewyns A, van de Heyning P, Gaertner L, Shapira Y, Henkin Y, Battelino S, Orzan E, Muzzi E, Marchi R, Free R, Frijns JHM, Voelker C, Winter M, Schrader D, Ganguly DH, Egra-Dagan D, Diab K, Dayxes N, Nanan A, Koji R, Karaosmanoğlu A, Günay Bulut E, Verbist B, Azadpour M, Mandala M, Valeria Goffi M, Polak M, Lee KYS, Wilson K, Friedmann DR, Rajeswaran R, Monsanto R, Cureoglu S, Driver S, Bošnjak R, Dundar G, Eroglu E. Sennaroglu L, et al. Among authors: palacios m. Cochlear Implants Int. 2024 Nov 28:1-18. doi: 10.1080/14670100.2024.2413273. Online ahead of print. Cochlear Implants Int. 2024. PMID: 39607757
Protect kelp forests.
Arafeh-Dalmau N, Olguín-Jacobson C, Earle S, Bello M, Lagger C, Mora-Soto A, Pantano C, Palacios M, Barbosa RV, Fica-Rojas E, Guajardo E, Aburto-Oropeza O, Eger A, Dayton P, Giraldo-Ospina A, Cavanaugh K, García-Pantoja J, Montaño-Moctezuma G, Possingham H, Sala E, Schoeman D, Torres-Moye G, Micheli F. Arafeh-Dalmau N, et al. Among authors: palacios m. Science. 2024 Nov 8;386(6722):629. doi: 10.1126/science.adr4814. Epub 2024 Nov 7. Science. 2024. PMID: 39509495 No abstract available.
Tachypnea in response to hypoxemia decreases with age in older patients.
Cuerpo S, Aguiló S, Alquézar-Arbé A, Fernández C, Burillo G, Jacob J, Montero-Pérez FJ, García-Lamberechts EJ, Piñera P, Blázquez BE, de la Iglesia CG, Quesada SF, Vaswani-Bulchand A, Rodríguez-Cabrera M, Aragüés PL, Díaz-Guerra MLP, González FXA, Alcaraz AP, Collado JM, Torres GJ, Fuentes L, Martos RM, López AR, Hernández RJG, García JP, Trian EM, Del Castillo JG, Miró Ò; members of the SIESTA network. Cuerpo S, et al. Geriatr Gerontol Int. 2024 Nov;24(11):1120-1129. doi: 10.1111/ggi.14965. Epub 2024 Oct 8. Geriatr Gerontol Int. 2024. PMID: 39380254
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.
Sitbon O, Skride A, Feldman J, Sahay S, Shlobin OA, McLaughlin V, Ghofrani HA, Langleben D, Parsley E, D'Souza G, Marmon T, Kamau-Kelley W, Jones R, Grewal R, Wring S, Palacios M, Naik H, Denning J, Lazarus HM, Humbert M. Sitbon O, et al. Among authors: palacios m. Lancet Respir Med. 2024 Nov;12(11):865-876. doi: 10.1016/S2213-2600(24)00226-1. Epub 2024 Sep 19. Lancet Respir Med. 2024. PMID: 39307144 Clinical Trial.
431 results